As shown in Fig. 6a, b, the activity of PKA was significantly decreased in SNU-368 cells with H1HR knockdown and significantly increased in HLE cells with H1HR overexpression, while PKC activity remained unchanged, suggesting that the PKA pathway is activated by H1HR in HCC cells. The gene discussed is PRRT2; the disease is hepatocellular carcinoma.